NextCure
Signal active
Organization
Contact Information
Overview
NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs. The Company is applying its proprietary platforms and know-how to identify novel and biologically relevant targets and develop first-in-class immunotherapy products.
About
Industries
Biotechnology, Health Care, Biopharma, Oncology
Founded
2015
Employees
51-100
Headquarters locations
Beltsville, Maryland, United States, North America
Social
Profile Resume
NextCure headquartered in United States, North America, operates in the Biotechnology, Health Care, Biopharma, Oncology sector. The company focuses on Biotechnology and has secured $19.8B in funding across 64 round(s). With a team of 51-100 employees, NextCure is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - NextCure, raised $67.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
4
Investors
6
Lead Investors
0
Total Funding Amount
$310.0M
Details
2
NextCure has raised a total of $310.0M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2018 | Early Stage Venture | 93.0M | ||
| 2016 | Early Stage Venture | 67.0M |
Investors
NextCure is funded by 30 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Sofinnova Investments | - | FUNDING ROUND - Sofinnova Investments | 67.0M |
| Pfizer | - | FUNDING ROUND - Pfizer | 67.0M |
| NextCure | - | FUNDING ROUND - NextCure | 67.0M |
| Alexandria | - | FUNDING ROUND - Alexandria | 67.0M |
Recent Activity
News
May 30, 2024
Globe Newswire - NextCure Presents Phase 1b Data on NC410 and Pembrolizumab Combination at ASCO 2024
News
Apr 17, 2024
GlobeNewswire - NextCure and LCB Present Preclinical Data on B7-H4 Antibody Drug Conjugate at AACR 2024
News
Apr 08, 2024
GlobeNewswire - NextCure and LCB Present Preclinical Data on B7-H4 Antibody Drug Conjugate at AACR 2024
News
Apr 04, 2024
EIN News - NextCure Appoints Dr. Rakesh Dixit to Scientific Advisory Board
News
Apr 04, 2024
Investing.com - NextCure adds oncology expert to advisory board By Investing.com
News
Apr 04, 2024
thefly.com - NextCure appoints Rakesh Dixit to Scientific Advisory Board